Systematic Analysis of the Transcriptome Profiles and Co-Expression Networks of Tumour Endothelial Cells Identifies Several Tumour-Associated Modules and Potential Therapeutic Targets in Hepatocellular Carcinoma.

hepatocellular carcinoma liver endothelial cells network analysis tumour associated endothelial cells

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
07 Apr 2021
Historique:
received: 17 02 2021
revised: 27 03 2021
accepted: 31 03 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 1 5 2021
Statut: epublish

Résumé

Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third most common cause of cancer-related death, with tumour associated liver endothelial cells being thought to be major drivers in HCC progression. This study aims to compare the gene expression profiles of tumour endothelial cells from the liver with endothelial cells from non-tumour liver tissue, to identify perturbed biologic functions, co-expression modules, and potentially drugable hub genes that could give rise to novel therapeutic targets and strategies. Gene Set Variation Analysis (GSVA) showed that cell growth-related pathways were upregulated, whereas apoptosis induction, immune and inflammatory-related pathways were downregulated in tumour endothelial cells. Weighted Gene Co-expression Network Analysis (WGCNA) identified several modules strongly associated to tumour endothelial cells or angiogenic activated endothelial cells with high endoglin (

Identifiants

pubmed: 33917186
pii: cancers13081768
doi: 10.3390/cancers13081768
pmc: PMC8067977
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Clin Cancer Res. 2009 Aug 1;15(15):4838-46
pubmed: 19638466
Hepatol Res. 2019 Oct;49(10):1195-1206
pubmed: 31177590
Bioinformatics. 2010 Apr 1;26(7):976-8
pubmed: 20179076
Bioessays. 1994 Dec;16(12):901-6
pubmed: 7840769
J Hepatol. 2017 Jan;66(1):212-227
pubmed: 27423426
BMC Cancer. 2011 Jun 08;11:230
pubmed: 21651811
Nat Rev Gastroenterol Hepatol. 2018 Sep;15(9):555-567
pubmed: 29844586
Med Sci Monit. 2021 Mar 04;27:e929023
pubmed: 33658475
Science. 2000 Aug 18;289(5482):1197-202
pubmed: 10947988
Ann Surg. 2015 May;261(5):947-55
pubmed: 25010665
Nat Methods. 2018 May;15(5):379-386
pubmed: 29630061
Pharmacol Rep. 2015 Aug;67(4):689-94
pubmed: 26321269
Drug Resist Updat. 2020 Jan;48:100662
pubmed: 31927437
Tumour Biol. 2015 Feb;36(2):737-45
pubmed: 25286761
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Biomolecules. 2020 Feb 12;10(2):
pubmed: 32059544
Sci Rep. 2018 Jan 12;8(1):622
pubmed: 29330528
Cancer Med. 2019 Mar;8(3):1269-1278
pubmed: 30714677
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Bioinformatics. 2004 Feb 12;20(3):307-15
pubmed: 14960456
Am J Pathol. 2012 Mar;180(3):1294-1307
pubmed: 22245217
Bioinformatics. 2011 Jun 15;27(12):1739-40
pubmed: 21546393
J Biotechnol. 2013 Oct 20;168(2):229-33
pubmed: 23994265
PLoS Biol. 2016 Jan 11;14(1):e1002349
pubmed: 26751069
Nat Cell Biol. 2017 Jun;19(6):639-652
pubmed: 28530660
Oncogene. 2015 Mar 5;34(10):1220-30
pubmed: 24662830
PeerJ. 2021 Jan 19;9:e10594
pubmed: 33552715
Nucleic Acids Res. 2018 Jan 4;46(D1):D1068-D1073
pubmed: 29156001
J Exp Clin Cancer Res. 2019 Jul 18;38(1):316
pubmed: 31319849
Cold Spring Harb Perspect Med. 2012 Mar;2(3):a006536
pubmed: 22393533
Chem Asian J. 2019 Nov 18;14(22):4035-4041
pubmed: 31251464
Blood. 1996 Jul 15;88(2):667-73
pubmed: 8695814
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
Biochemistry. 2001 Jan 30;40(4):1117-23
pubmed: 11170436
Br J Cancer. 2009 Apr 7;100(7):1073-86
pubmed: 19293795
Nat Rev Gastroenterol Hepatol. 2020 Apr;17(4):238-251
pubmed: 31900465
J Gastroenterol. 2009;44 Suppl 19:108-11
pubmed: 19148803
Am J Pathol. 2012 Mar;180(3):1283-1293
pubmed: 22245726
Cancer Res. 2013 Feb 1;73(3):1190-200
pubmed: 23204226
Cancer Lett. 2008 Aug 28;267(2):226-44
pubmed: 18579287
J Vasc Res. 2008;45(1):78-86
pubmed: 17901709
Cancer Res. 2006 Feb 1;66(3):1640-7
pubmed: 16452223
Bioinformatics. 2009 Feb 1;25(3):415-6
pubmed: 19106121
J Hepatol. 2017 Aug;67(2):302-309
pubmed: 28336466
Front Immunol. 2019 Feb 08;10:147
pubmed: 30800123
Biochem Biophys Res Commun. 2010 Mar 5;393(2):253-8
pubmed: 20117083
N Engl J Med. 2020 May 14;382(20):1894-1905
pubmed: 32402160
Sci Rep. 2019 Nov 21;9(1):17283
pubmed: 31754223
Stat Med. 1990 Jul;9(7):811-8
pubmed: 2218183
J Hepatol. 2004 Nov;41(5):864-80
pubmed: 15519663
Cancer Cell. 2020 Jan 13;37(1):21-36.e13
pubmed: 31935371
J Clin Oncol. 2015 Feb 20;33(6):559-66
pubmed: 25547503
Biochem Biophys Res Commun. 2010 Apr 16;394(4):947-54
pubmed: 20302845
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
EBioMedicine. 2016 Dec;14:32-43
pubmed: 27852524
Cancer Lett. 2018 Apr 28;420:156-167
pubmed: 29410067
Front Oncol. 2020 Nov 02;10:578816
pubmed: 33224879
Cancer Cell. 2007 Jun;11(6):539-54
pubmed: 17560335
Mol Oncol. 2017 Jun;11(6):640-654
pubmed: 28371273
BMC Bioinformatics. 2013 Jan 16;14:7
pubmed: 23323831
Cell Cycle. 2016;15(7):895-907
pubmed: 27019372
Comput Biol Med. 2015 Aug;63:219-27
pubmed: 26093789
Cancer Sci. 2017 Oct;108(10):1921-1926
pubmed: 28763139
J Immunol. 2000 Nov 1;165(9):5269-77
pubmed: 11046061
Biochem Biophys Res Commun. 2012 Mar 30;420(1):29-35
pubmed: 22390936
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Front Genet. 2020 Jan 10;10:1306
pubmed: 31998366
Sci Rep. 2017 Mar 13;7:44356
pubmed: 28287163
Expert Opin Drug Deliv. 2020 Dec 27;:1-22
pubmed: 33295218
Nature. 2001 May 3;411(6833):41-2
pubmed: 11333967
Exp Ther Med. 2016 Oct;12(4):2109-2119
pubmed: 27703495
J Biochem. 2013 Mar;153(3):243-9
pubmed: 23293323
J Exp Clin Cancer Res. 2019 Aug 22;38(1):368
pubmed: 31439015
Nucleic Acids Res. 2016 Jan 4;44(D1):D488-94
pubmed: 26481357
Cancer Cell. 2005 May;7(5):457-68
pubmed: 15894266
Bioinformatics. 2007 May 15;23(10):1274-81
pubmed: 17344234
Nature. 2019 Aug;572(7768):199-204
pubmed: 31292543
J Mol Cell Biol. 2021 Apr 10;13(1):1-2
pubmed: 32997747
PLoS One. 2012;7(4):e34206
pubmed: 22509281
Anticancer Res. 2019 May;39(5):2251-2258
pubmed: 31092416
Nucleic Acids Res. 2016 Jan 4;44(D1):D1036-44
pubmed: 26531824
J Cardiovasc Pharmacol. 2007 Sep;50(3):274-80
pubmed: 17878755
Oncotarget. 2017 Apr 18;8(16):27593-27602
pubmed: 28187440
Sci Rep. 2017 Mar 31;7:45846
pubmed: 28361988
BMC Syst Biol. 2012 Jun 12;6:63
pubmed: 22691535
EMBO J. 2004 Oct 13;23(20):4018-28
pubmed: 15385967
Int J Mol Sci. 2018 Apr 24;19(5):
pubmed: 29695087
Oncogene. 2015 Jan 22;34(4):525-30
pubmed: 24469058
Arterioscler Thromb Vasc Biol. 2002 Jun 1;22(6):887-93
pubmed: 12067894

Auteurs

Thomas Mohr (T)

ScienceConsult-DI Thomas Mohr KG, Enzianweg 10a, A-2353 Guntramsdorf, Austria.
Institute of Cancer Research, Department of Medicine I, Medical University of Vienna and Comprehensive Cancer Center, A-1090 Vienna, Austria.

Sonja Katz (S)

ScienceConsult-DI Thomas Mohr KG, Enzianweg 10a, A-2353 Guntramsdorf, Austria.

Verena Paulitschke (V)

Department of Dermatology, Medical University of Vienna, A-1090 Vienna, Austria.

Nadim Aizarani (N)

Max-Planck-Institute of Immunobiology and Epigenetics, D-79108 Freiburg, Germany.

Alexander Tolios (A)

Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, A-1090 Vienna, Austria.
Center of Physiology and Pharmacology, Institute of Vascular Biology and Thrombosis Research, Medical University of Vienna, A-1090 Vienna, Austria.
Section of Artificial Intelligence and Decision Support, Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, A-1090 Vienna, Austria.

Classifications MeSH